288 related articles for article (PubMed ID: 26536590)
1. Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.
Akhtar S; Chandrasekhar B; Attur S; Dhaunsi GS; Yousif MH; Benter IF
PLoS One; 2015; 10(11):e0141657. PubMed ID: 26536590
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
Akhtar S; Yousif MH; Dhaunsi GS; Chandrasekhar B; Al-Farsi O; Benter IF
Br J Pharmacol; 2012 Mar; 165(5):1390-400. PubMed ID: 21806601
[TBL] [Abstract][Full Text] [Related]
3. Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.
Akhtar S; Yousif MH; Dhaunsi GS; Sarkhouh F; Chandrasekhar B; Attur S; Benter IF
PLoS One; 2013; 8(6):e67813. PubMed ID: 23826343
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Yousif MH; Dhaunsi GS; Makki BM; Qabazard BA; Akhtar S; Benter IF
Pharmacol Res; 2012 Sep; 66(3):269-75. PubMed ID: 22580236
[TBL] [Abstract][Full Text] [Related]
6. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
Touyz RM; Wu XH; He G; Salomon S; Schiffrin EL
Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594
[TBL] [Abstract][Full Text] [Related]
7. The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes.
Benter IF; Sarkhou F; Al-Khaldi AT; Chandrasekhar B; Attur S; Dhaunsi GS; Yousif MH; Akhtar S
J Drug Target; 2015; 23(6):506-18. PubMed ID: 26114862
[TBL] [Abstract][Full Text] [Related]
8. Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
Ogata Y; Nemoto W; Yamagata R; Nakagawasai O; Shimoyama S; Furukawa T; Ueno S; Tan-No K
Eur J Pain; 2019 Apr; 23(4):739-749. PubMed ID: 30421564
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) inhibits vascular calcification in rats.
Sui YB; Chang JR; Chen WJ; Zhao L; Zhang BH; Yu YR; Tang CS; Yin XH; Qi YF
Peptides; 2013 Apr; 42():25-34. PubMed ID: 23291307
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
Wong TP; Ho KY; Ng EK; Debnam ES; Leung PS
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E669-81. PubMed ID: 22811473
[TBL] [Abstract][Full Text] [Related]
11. Naked Polyamidoamine Polymers Intrinsically Inhibit Angiotensin II-Mediated EGFR and ErbB2 Transactivation in a Dendrimer Generation- and Surface Chemistry-Dependent Manner.
Akhtar S; El-Hashim AZ; Chandrasekhar B; Attur S; Benter IF
Mol Pharm; 2016 May; 13(5):1575-86. PubMed ID: 26985693
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
Bokemeyer D; Schmitz U; Kramer HJ
Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D.
Li F; Malik KU
J Pharmacol Exp Ther; 2005 Mar; 312(3):1043-54. PubMed ID: 15525798
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
Zhang F; Li S; Song J; Liu J; Cui Y; Chen H
Atherosclerosis; 2017 Jun; 261():90-98. PubMed ID: 28283184
[TBL] [Abstract][Full Text] [Related]
15. Ang-(1-7)/ MAS1 receptor axis inhibits allergic airway inflammation via blockade of Src-mediated EGFR transactivation in a murine model of asthma.
El-Hashim AZ; Khajah MA; Babyson RS; Renno WM; Ezeamuzie CI; Benter IF; Akhtar S
PLoS One; 2019; 14(11):e0224163. PubMed ID: 31675376
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.
Nemoto W; Ogata Y; Nakagawasai O; Yaoita F; Tadano T; Tan-No K
Eur J Pain; 2014 Nov; 18(10):1471-9. PubMed ID: 24733750
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.
Bihl JC; Zhang C; Zhao Y; Xiao X; Ma X; Chen Y; Chen S; Zhao B; Chen Y
Vascul Pharmacol; 2015 Oct; 73():115-123. PubMed ID: 26264508
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
Su Z; Zimpelmann J; Burns KD
Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
[TBL] [Abstract][Full Text] [Related]
20. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
